HLA-B27 StripAssay®
HLA-B27 Subtype Detection for Autoimmune Disease
The HLA-B27 StripAssay® detects relevant subtypes of the HLA-B27 gene, providing definitive positive or negative results to support differential diagnosis of autoimmune and inflammatory conditions where overlapping symptoms make clinical diagnosis difficult.
Key Features
HLA-B27 Subtype Differentiation
Detects relevant subtypes of the HLA-B27 gene to support differential diagnosis of autoimmune conditions.
Definitive Positive/Negative Result
Clearly differentiates HLA-B27-positive from negative patients, resolving diagnostic ambiguity from overlapping symptoms.
Ankylosing Spondylitis Support
Key tool for supporting diagnosis of ankylosing spondylitis, reactive arthritis, and related HLA-B27-associated diseases.
PCR & Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for reliable subtype identification.
For Research Use Only (RUO)
HLA-B27 StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.